Literature DB >> 29338958

Recommendations of the Second Panel on Cost Effectiveness in Health and Medicine: A Reference, Not a Rule Book.

Cristina Carias1, Harrell W Chesson2, Scott D Grosse3, Rui Li4, Martin I Meltzer1, Gabrielle F Miller5, Louise B Murphy6, Tursynbek A Nurmagambetov7, Jamison J Pike8, Hilary K Whitham9.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29338958      PMCID： PMC6038124          DOI： 10.1016/j.amepre.2017.11.013

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN： 0749-3797            Impact factor:   5.043


× No keyword cloud information.
  6 in total

Review 1.  CONCEPTUALIZATIONS OF THE SOCIETAL PERSPECTIVE WITHIN ECONOMIC EVALUATIONS: A SYSTEMATIC REVIEW.

Authors:  Ruben M W A Drost; Ingeborg M van der Putten; Dirk Ruwaard; Silvia M A A Evers; Aggie T G Paulus
Journal:  Int J Technol Assess Health Care       Date:  2017-06-23       Impact factor: 2.188

Review 2.  Economic value of home-based, multi-trigger, multicomponent interventions with an environmental focus for reducing asthma morbidity a community guide systematic review.

Authors:  Tursynbek A Nurmagambetov; Sarah Beth L Barnett; Verughese Jacob; Sajal K Chattopadhyay; David P Hopkins; Deidre D Crocker; Gema G Dumitru; Stella Kinyota
Journal:  Am J Prev Med       Date:  2011-08       Impact factor: 5.043

3.  The economic impact of an urban asthma management program.

Authors:  Michelle M Cloutier; Scott D Grosse; Dorothy B Wakefield; Tursynbek A Nurmagambetov; Clive M Brown
Journal:  Am J Manag Care       Date:  2009-06       Impact factor: 2.229

4.  Retrospective Assessment of Cost Savings From Prevention: Folic Acid Fortification and Spina Bifida in the U.S.

Authors:  Scott D Grosse; Robert J Berry; J Mick Tilford; James E Kucik; Norman J Waitzman
Journal:  Am J Prev Med       Date:  2016-01-11       Impact factor: 5.043

5.  Economic evaluation of the routine childhood immunization program in the United States, 2009.

Authors:  Fangjun Zhou; Abigail Shefer; Jay Wenger; Mark Messonnier; Li Yan Wang; Adriana Lopez; Matthew Moore; Trudy V Murphy; Margaret Cortese; Lance Rodewald
Journal:  Pediatrics       Date:  2014-03-03       Impact factor: 7.124

6.  Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.

Authors:  Gillian D Sanders; Peter J Neumann; Anirban Basu; Dan W Brock; David Feeny; Murray Krahn; Karen M Kuntz; David O Meltzer; Douglas K Owens; Lisa A Prosser; Joshua A Salomon; Mark J Sculpher; Thomas A Trikalinos; Louise B Russell; Joanna E Siegel; Theodore G Ganiats
Journal:  JAMA       Date:  2016-09-13       Impact factor: 56.272
  6 in total
  12 in total

Review 1.  Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review.

Authors:  Jamison Pike; Scott D Grosse
Journal:  Appl Health Econ Health Policy       Date:  2018-12       Impact factor: 2.561

2.  The business case for quality improvement.

Authors:  Hannah Ryan Fischer; Scott Davis Duncan
Journal:  J Perinatol       Date:  2020-03-30       Impact factor: 2.521

3.  Transoral incisionless fundoplication is cost-effective for treatment of gastroesophageal reflux disease.

Authors:  Thomas R McCarty; Pichamol Jirapinyo; Lyndon P James; Sanchit Gupta; Walter W Chan; Christopher C Thompson
Journal:  Endosc Int Open       Date:  2022-07-15

4.  Behavioral cancer pain intervention using videoconferencing and a mobile application for medically underserved patients: Rationale, design, and methods of a prospective multisite randomized controlled trial.

Authors:  Sarah A Kelleher; Joseph G Winger; Hannah M Fisher; Shannon N Miller; Shelby D Reed; Beverly E Thorn; Bonnie Spring; Gregory P Samsa; Catherine M Majestic; Rebecca A Shelby; Linda M Sutton; Francis J Keefe; Tamara J Somers
Journal:  Contemp Clin Trials       Date:  2021-01-23       Impact factor: 2.261

5.  Equity and the financial costs of informal caregiving in palliative care: a critical debate.

Authors:  Clare Gardiner; Jackie Robinson; Michael Connolly; Claire Hulme; Kristy Kang; Christine Rowland; Phil Larkin; David Meads; Tessa Morgan; Merryn Gott
Journal:  BMC Palliat Care       Date:  2020-05-19       Impact factor: 3.234

6.  New model of integrated care for uncontrolled type 2 diabetes in a retrospective, underserved adult population in the USA: a study protocol for an effectiveness and cost-effectiveness analysis.

Authors:  Rita Bosetti; Laila Tabatabai; George Naufal; Rosbel Brito; Bita Kash
Journal:  BMJ Open       Date:  2020-07-23       Impact factor: 2.692

7.  A cost-benefit analysis framework for preventive health interventions to aid decision-making in Australian governments.

Authors:  Jaithri Ananthapavan; Marj Moodie; Andrew Milat; Lennert Veerman; Elizabeth Whittaker; Rob Carter
Journal:  Health Res Policy Syst       Date:  2021-12-19

8.  Real-World Six-Year National Cost-Minimization Analysis of IncobotulinumtoxinA and OnabotulinumtoxinA in the VA/DoD Healthcare Systems.

Authors:  Rashid Kazerooni; Ileana M Howard; Adrienne M Keener; Mark Bounthavong
Journal:  Clinicoecon Outcomes Res       Date:  2021-06-30

9.  Cost-effectiveness of Anti-CD19 chimeric antigen receptor T-Cell therapy in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. A societal view.

Authors:  Frederick W Thielen; Annemieke van Dongen-Leunis; Alexander M M Arons; Judith R Ladestein; Peter M Hoogerbrugge; Carin A Uyl-de Groot
Journal:  Eur J Haematol       Date:  2020-05-04       Impact factor: 2.997

10.  Evidence-based recommendations for economic evaluations in spine surgery: study protocol for a Delphi consensus.

Authors:  Ruud Droeghaag; Valérie N E Schuermans; Sem M M Hermans; Anouk Y J M Smeets; Inge J M H Caelers; Mickaël Hiligsmann; Wouter L W van Hemert; Silvia Evers; Henk van Santbrink
Journal:  BMJ Open       Date:  2021-12-23       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.